Royal Bank Of Canada Atossa Therapeutics, Inc. Transaction History
Royal Bank Of Canada
- $579 Billion
- Q3 2025
A detailed history of Royal Bank Of Canada transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 745 shares of ATOS stock, worth $603. This represents 0.0% of its overall portfolio holdings.
Number of Shares
745
Previous 7,795
90.44%
Holding current value
$603
Previous $6,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding ATOS
# of Institutions
74Shares Held
26.8MCall Options Held
79.5KPut Options Held
98.8K-
Black Rock Inc. New York, NY9.2MShares$7.45 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.08MShares$4.92 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2.95MShares$2.39 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.67MShares$1.35 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.55MShares$1.25 Million0.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $103M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...